March 15, 2017 / 12:29 PM / 4 months ago

BRIEF-Immunomedics says IMMU-132 produces early, durable responses in patients

1 Min Read

March 15 (Reuters) - Immunomedics Inc:

* Immunomedics -results demonstrate treatment with IMMU-132 produces early and durable responses in patients with metastatic triple-negative breast cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below